Consortium provide €100m for Symphogen
A consortium led by Novo A/S, joined by Essex Woodlands, Gilde Healthcare Partners and Danish Pension Fund PKA, has provided €100m for Symphogen, making it the largest funding round ever in Europe for a private biotech company.
The company has previously completed a number of funding rounds from investors such as Novo, Essex Woodlands, Vækstfonden, Scandinavian Life Science Ventures, Sunstone Capital and Gilde Healthcare Partners. The recent funding round will accelerate the advancement of the company's lead clinical oncology product.
Novo and Essex Woodlands are providing 70% of the investment with the remainder provided by PKA. Essex is providing equity for the transaction through its Essex Woodlands Fund VIII.
Founded in 2000 and headquartered in Copenhagen, Symphogen is a biotechnology company specialising in therapeutic products based on natural human antibodies for the treatment and prevention of human disease.
The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.
If you have any information regarding this transaction, please contact Viktor Lundvall on +44 20 7004 7476 or viktor.lundvall@incisivemedia.com
More on Nordics
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Trind VC plans up to five early-stage investments in next six months
VC has deployed around 10% of its second, EUR 55m fund and plans to invest in up to 40 startups
Letter from the editor: Unquote is moving to Mergermarket
Unquote Editor Harriet Matthews outlines Unquote.com's upcoming move to the Mergermarket platform and the new capabilities and intelligence that this brings to Unquote readers
Main Capital’s Assessio to be sold to Pollen Street
Recruitment software company tripled in revenue under Main Capital’s ownership
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater